866-997-4948(US-Canada Toll Free)

Pressure Ulcers - Pipeline Review, H1 2017

Published By :

Global Markets Direct

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 37 Pages

Pressure Ulcers - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pressure Ulcers Pipeline Review, H1 2017, provides an overview of the Pressure Ulcers (Dermatology) pipeline landscape.

Pressure ulcers are an injury that breaks down the skin and underlying tissue. The parts of the body most at risk of developing pressure ulcers are those that are not covered by a large amount of body fat and are in direct contact with a supporting surface (bed or a wheelchair). Causes include continuous pressure, friction and shear. Treatment includes antibiotics and nutrition.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Pressure Ulcers Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Pressure Ulcers (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pressure Ulcers (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pressure Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Preclinical stages are 3 and 5 respectively.

Pressure Ulcers (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Pressure Ulcers (Dermatology).
- The pipeline guide reviews pipeline therapeutics for Pressure Ulcers (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Pressure Ulcers (Dermatology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Pressure Ulcers (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Pressure Ulcers (Dermatology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Pressure Ulcers (Dermatology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Pressure Ulcers (Dermatology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Pressure Ulcers - Overview
Pressure Ulcers - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Pressure Ulcers - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Pressure Ulcers - Companies Involved in Therapeutics Development
EyeGene Inc
Izun Pharmaceuticals Corp
MediWound Ltd
NovaLead Pharma Pvt Ltd
RegeneRx Biopharmaceuticals Inc
RMB-Research GmbH
Pressure Ulcers - Drug Profiles
AG-100 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EG-Decorin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EscharEx - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IZN-6D4 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NLP-328 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RGN-137 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Statmicoll - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Stem Cell Therapy for Pressure Ulcers - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Pressure Ulcers - Dormant Projects
Pressure Ulcers - Discontinued Products
Pressure Ulcers - Product Development Milestones
Featured News & Press Releases
Aug 24, 2016: MediWound's EscharEx to be Featured at International Society for Burn Injuries 2016
Dec 04, 2015: RegeneRx Receives Chinese Patent for Key TB4 Peptide Fragment
Jan 09, 2009: RegeneRx Reports Phase II Pressure Ulcer Trial Results
Sep 22, 2008: RegeneRx/Sigma-Tau Completes Patient Enrollment Of Second Phase II Clinical Trial With RGN-137
Aug 20, 2008: RegeneRx Completes Patient Enrollment Of First Phase II Clinical Trial
Nov 02, 2004: RegeneRx Gets Cleared To Initiate Phase II Clinical Trial With T4 For Chronic Pressure Ulcers
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Pressure Ulcers, H1 2017
Number of Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Pressure Ulcers - Pipeline by EyeGene Inc, H1 2017
Pressure Ulcers - Pipeline by Izun Pharmaceuticals Corp, H1 2017
Pressure Ulcers - Pipeline by MediWound Ltd, H1 2017
Pressure Ulcers - Pipeline by NovaLead Pharma Pvt Ltd, H1 2017
Pressure Ulcers - Pipeline by RegeneRx Biopharmaceuticals Inc, H1 2017
Pressure Ulcers - Pipeline by RMB-Research GmbH, H1 2017
Pressure Ulcers - Dormant Projects, H1 2017
Pressure Ulcers - Discontinued Products, H1 2017

List of Figures
Number of Products under Development for Pressure Ulcers, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products by Targets, H1 2017
Number of Products by Stage and Targets, H1 2017
Number of Products by Mechanism of Actions, H1 2017
Number of Products by Stage and Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Routes of Administration, H1 2017
Number of Products by Molecule Types, H1 2017
Number of Products by Stage and Molecule Types, H1 2017

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *